ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/04/16 | 1,600 | 1,623 | 1,576 | 1,583 | -18 | -1.1% | 544,000 |
2019/04/15 | 1,577 | 1,601 | 1,533 | 1,601 | +8 | +0.5% | 753,000 |
2019/04/12 | 1,593 | 1,742 | 1,548 | 1,593 | -8 | -0.5% | 2,824,800 |
2019/04/11 | 1,634 | 1,644 | 1,565 | 1,601 | -22 | -1.4% | 714,200 |
2019/04/10 | 1,619 | 1,653 | 1,603 | 1,623 | +21 | +1.3% | 784,800 |
2019/04/09 | 1,645 | 1,659 | 1,572 | 1,602 | -12 | -0.7% | 794,400 |
2019/04/08 | 1,612 | 1,687 | 1,590 | 1,614 | -29 | -1.8% | 940,600 |
2019/04/05 | 1,595 | 1,671 | 1,595 | 1,643 | +40 | +2.5% | 1,210,800 |
2019/04/04 | 1,587 | 1,630 | 1,547 | 1,603 | +28 | +1.8% | 792,400 |
2019/04/03 | 1,598 | 1,640 | 1,565 | 1,575 | -12 | -0.8% | 901,500 |
2019/04/02 | 1,678 | 1,681 | 1,525 | 1,587 | -108 | -6.4% | 1,475,000 |
2019/04/01 | 1,729 | 1,736 | 1,689 | 1,695 | -26 | -1.5% | 530,300 |
2019/03/29 | 1,750 | 1,757 | 1,700 | 1,721 | -5 | -0.3% | 525,800 |
2019/03/28 | 1,771 | 1,825 | 1,706 | 1,726 | -5 | -0.3% | 1,252,500 |
2019/03/27 | 1,697 | 1,741 | 1,675 | 1,731 | +34 | +2% | 808,400 |
2019/03/26 | 1,780 | 1,781 | 1,685 | 1,697 | -53 | -3% | 1,027,600 |
2019/03/25 | 1,672 | 1,789 | 1,662 | 1,750 | +8 | +0.5% | 1,335,300 |
2019/03/22 | 1,801 | 1,843 | 1,720 | 1,742 | -96 | -5.2% | 1,690,400 |
2019/03/20 | 1,911 | 1,932 | 1,837 | 1,838 | -92 | -4.8% | 1,408,200 |
2019/03/19 | 1,992 | 2,017 | 1,902 | 1,930 | -68 | -3.4% | 1,502,100 |
2019/03/18 | 1,982 | 2,042 | 1,960 | 1,998 | +56 | +2.9% | 1,910,800 |
2019/03/15 | 2,001 | 2,032 | 1,934 | 1,942 | -63 | -3.1% | 1,496,600 |
2019/03/14 | 2,050 | 2,064 | 1,999 | 2,005 | -24 | -1.2% | 1,081,100 |
2019/03/13 | 1,987 | 2,069 | 1,969 | 2,029 | +15 | +0.7% | 2,822,700 |
2019/03/12 | 1,948 | 2,176 | 1,945 | 2,014 | +123 | +6.5% | 7,549,800 |
2019/03/11 | 1,886 | 1,925 | 1,800 | 1,891 | -31 | -1.6% | 2,587,700 |
2019/03/08 | 1,955 | 1,995 | 1,904 | 1,922 | -73 | -3.7% | 2,359,300 |
2019/03/07 | 1,897 | 2,051 | 1,887 | 1,995 | +65 | +3.4% | 3,482,700 |
2019/03/06 | 1,991 | 2,018 | 1,912 | 1,930 | -48 | -2.4% | 1,345,900 |
2019/03/05 | 1,945 | 1,985 | 1,886 | 1,978 | +14 | +0.7% | 1,697,700 |
2019/03/04 | 1,970 | 2,004 | 1,909 | 1,964 | +10 | +0.5% | 2,153,900 |
2019/03/01 | 2,041 | 2,113 | 1,932 | 1,954 | +13 | +0.7% | 5,392,600 |
2019/02/28 | 2,170 | 2,210 | 1,870 | 1,941 | -148 | -7.1% | 7,815,600 |
2019/02/27 | 1,950 | 2,089 | 1,935 | 2,089 | +400 | +23.7% | 3,791,100 |
2019/02/26 | 1,745 | 1,934 | 1,665 | 1,689 | -53 | -3% | 7,084,700 |
2019/02/25 | 1,703 | 1,770 | 1,671 | 1,742 | +57 | +3.4% | 2,399,100 |
2019/02/22 | 1,631 | 1,685 | 1,626 | 1,685 | +36 | +2.2% | 1,238,700 |
2019/02/21 | 1,720 | 1,724 | 1,640 | 1,649 | -19 | -1.1% | 1,335,800 |
2019/02/20 | 1,665 | 1,710 | 1,613 | 1,668 | +22 | +1.3% | 1,662,900 |
2019/02/19 | 1,660 | 1,717 | 1,620 | 1,646 | -37 | -2.2% | 1,802,700 |
2019/02/18 | 1,750 | 1,772 | 1,658 | 1,683 | -78 | -4.4% | 2,327,500 |
2019/02/15 | 1,685 | 1,811 | 1,685 | 1,761 | +42 | +2.4% | 4,492,600 |
2019/02/14 | 1,711 | 1,924 | 1,603 | 1,719 | +13 | +0.8% | 12,850,100 |
2019/02/13 | 1,400 | 1,706 | 1,387 | 1,706 | +300 | +21.3% | 5,009,600 |
2019/02/12 | 1,450 | 1,577 | 1,388 | 1,406 | +128 | +10% | 7,027,900 |
2019/02/08 | 1,209 | 1,290 | 1,204 | 1,278 | +50 | +4.1% | 1,363,700 |
2019/02/07 | 1,273 | 1,305 | 1,224 | 1,228 | -22 | -1.8% | 1,465,700 |
2019/02/06 | 1,251 | 1,275 | 1,228 | 1,250 | -21 | -1.7% | 713,300 |
2019/02/05 | 1,251 | 1,284 | 1,221 | 1,271 | -2 | -0.2% | 1,312,100 |
2019/02/04 | 1,237 | 1,335 | 1,198 | 1,273 | +186 | +17.1% | 4,871,000 |
1551~
1600
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
Chordia | 18,000円 | - | - | 0.00% | - | 3.83倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
セルソース | 62,300円 | - | - | 0.80% | 48.41倍 | 2.09倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム